Are Germany and Italy standing in the way of progress in European stem cell research?

A report published last week from the European Science federation (ESF) has given 27 different countries one of four possible statuses based on the permissiveness of their stem cell policies. With the possibility of being deemed either very permissive with regards to human Embryonic Stem Cells, permissive with restrictions, restrictive by default, or very restrictive, the authors of the paper, …

Whitepaper: Growth Kinetics of Human Mesenchymal Stem Cells in a 3L Single-Use, Stirred Tank Bioreactor (EMD Millipore)

Human mesenchymal stem cells hold great promise as therapeutic agents because of their differentiation ability (thus their potential to replace damaged tissue) and for their immunomodulatory properties. A large number of clinical trials are underway that are using hMSCs in a variety of indications; hMSCs are also being used in drug discovery as a replacement for primary cells and animal …